Monitoring neonatal abstinence syndrome in buprenorphine-exposed in vitro fertilization twins: A case study

References

• Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med. 2012;9:e1001356.
   PubMed Web of Science ®Google Scholar
• Hart R, Norman RJ. The longer-term health outcomes for children born as a result of IVF treatment. Part II—mental health and development outcomes. Hum Reprod Update. 2013;19:244–250.
   PubMed Web of Science ®Google Scholar
• Kern R. IVF-Register Jahresbericht 2010. Vienna, Austria: Gesundheit Österreich GmbH, Bundesminiterium für Gesundheit; 2010.
   Google Scholar
• Fan C, Sun Y, Yang J, Ye J, Wang S. Maternal and neonatal outcomes in dichorionic twin pregnancies following IVF treatment: a hospital-based comparative study. Int J Clin Exp Pathol. 2013;6:2199–2207.
   PubMed Web of Science ®Google Scholar
• Tuchman E. Women and addiction: the importance of gender issues in substance abuse research. J Addict Dis. 2010;29:127–138.
   PubMed Web of Science ®Google Scholar
• Winklbaur-Hausknost B, Jagsch R, Graf-Rohrmeister K, et al. Lessons learned from a comparison of evidence-based research in pregnant opioid-dependent women. Hum Psychopharmacol. 2013;28:15–24.
   PubMed Web of Science ®Google Scholar
• Winklbaur B, Kopf N, Ebner N, Jung E, Thau K, Fischer G. Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates. Addiction. 2008;103:1429–1440.
   PubMed Web of Science ®Google Scholar
• Jones H, Kaltenbach K, Heil S, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363:2320–2331.
   PubMed Web of Science ®Google Scholar
• Fischer G, Ortner R, Rohrmeister K, et al. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction. 2006;101:275–281.
   PubMed Web of Science ®Google Scholar
• Brandt L, Fischberger S, Unger A, Jagsch R, Moser L, Fischer G. Neonatal abstinence syndrome after intrauterine opioid exposure: standards, cost-effectiveness of treatment and maternal rights. HARCP. 2015;17(2–3):35–44.
   Google Scholar
• Osborne DA, Jeffrey HE, Cole MJ. Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Syst Rev. 2010;(10):CD002059.
   Google Scholar
• Nayeri F, Sheikh M, Kalani, M, et al. Phenobarbital vs. morphine in the management of neonatal abstinence syndrome, a randomized control trial. BMC Pediatrics. 2015;15:57.
   PubMed Web of Science ®Google Scholar
• Kalra SK, Barnhart KT. In vitro fertilization and adverse childhood outcomes: what we know, where we are going, and how we will get there. A glimpse into what lies behind and beckons ahead. Fertil Steril. 2011;95:1887–1889.
   PubMed Web of Science ®Google Scholar
• Wright VC, Chang J, Jeng G, Chen M, Macaluso M. Assisted reproductive technology surveillance—United States, 2004. MMWR Surveill Summ. 2007; 56:561–522.
   Google Scholar
• Bower C, Hansen M. Assisted reproductive technologies and birth outcomes: overview of recent systematic reviews. Reprod Fertil Dev. 2005;17:329–333.
   PubMed Web of Science ®Google Scholar
• Hart R, Norman RJ. The longer-term health outcomes for children born as a result of IVF treatment: part I—general health outcomes. Hum Reprod Update. 2013;19:232–243.
   PubMed Web of Science ®Google Scholar
• Beydoun HA, Sicignano N, Beydoun MA, et al. A cross-sectional evaluation of the first cohort of young adults conceived by in vitro fertilization in the United States. Fertil Steril. 2010;94:2043–2049.
   PubMed Web of Science ®Google Scholar
• Wahlsten SV, Sarman I. Neurobehavioural development of preschool-age children born to addicted mothers given opiate maintenance treatment with buprenorphine during pregnancy. Acta Paediatr. 2013;102:544–549.
   PubMed Web of Science ®Google Scholar
• Salo S, Kivistö K, Korja R, et al. Emotional availability, parental self-efficacy beliefs, and child development in caregiver-child relationships with buprenorphine-exposed 3-year-olds. Parent Sci Pract. 2009;9:244–259.
   Web of Science ®Google Scholar
• Baldacchino A, Arbuckle K, Petrie DJ, McCowan C. Neurobehavioral consequences of chronic intrauterine opioid exposure in infants and preschool children: a systematic review and meta-analysis. BMC Psychiatry. 2014;14:104.
   PubMed Web of Science ®Google Scholar
• Kivistö K, Tupola S, Kivitie-Kallio S. Prenatally buprenorphine-exposed children: health to 3 years of age. Eur J Pediatr. 2015;174:1525–1533.
   PubMed Web of Science ®Google Scholar
• Petterson SM, Albers AB. Effects of poverty and maternal depression on early child development. Child Dev. 2001;72:1794–1813.
   PubMed Web of Science ®Google Scholar
• Benningfield MM, Arria AM, Kaltenbach K, et al. Co-occurring psychiatric symptoms are associated with increased psychological, social and medical impairment in opioid dependent pregnant women. Am J Addict. 2010;19:416–421.
   PubMed Web of Science ®Google Scholar
• Wagner KD, Hudson SM, Latka MH, et al. The effect of intimate partner violence on receptive syringe sharing among young female injection drug users: an analysis of mediation effects. AIDS Behav. 2009;13:217–224.
   PubMed Web of Science ®Google Scholar
• Metz V, Köchl B, Fischer G. Should pregnant women with substance use disorders be managed differently? Neuropsychiatry. 2012;2:29–41.
   PubMed Web of Science ®Google Scholar
• Fagerström K, Schneider N. Measuring nicotine dependence: a review of the Fagerström Tolerance Questionnaire. J Behav Med. 1989;12:159–182.
   PubMed Web of Science ®Google Scholar
• Gsellhofer B, Küfner H, Vogt M, Weiler D. European Addiction Severity Index (Europ-ASI)—Manual für Training und Durchführung. Hohengehren, Germany: Schneider-Verlag; 1999.
   Google Scholar
• Finnegan L, Connaughton J, Kron R, Emich J. Neonatal abstinence syndrome: assessment and management. Addict Dis. 1975;2:141–158.
   PubMedGoogle Scholar
• Metz V, Jagsch R, Ebner N, et al. Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women. Hum Psychopharmacol. 2011;26:412–421.
   PubMed Web of Science ®Google Scholar
• Jones H, Johnson R, Jasinski D, et al. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend. 2005;79:1–10.
   PubMed Web of Science ®Google Scholar
• Lejeune C, Simmat-Durrand L, Gourarier L, Aubisson S, Groupe d'Etudes Grossesse et Addictions (GEGA). Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenorphine substitution. Drug Alcohol Depend. 2006;82:250–257.
   PubMed Web of Science ®Google Scholar
• Welle-Strand GK, Skurtveit S, Jansson LM, Bakstad B, Bjarkø L, Ravndal E. Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants. Acta Paediatr. 2013;102:1060–1066.
   PubMed Web of Science ®Google Scholar
• Hytinantti T, Kahila H, Renlund M, Järvenpää AL, Halmesmäki E, Kivitie-Kallio S. Neonatal outcome of 58 infants exposed to maternal buprenorphine in utero. Acta Paediatr. 2008;97:1040–1044.
   PubMed Web of Science ®Google Scholar
• Winklbaur B, Baewert A, Jagsch R, et al. Association between prenatal tobacco exposure and outcome of neonates born to opioid-maintained mothers. Implications for treatment. Eur Addict Res. 2009;15:150–156.
   PubMed Web of Science ®Google Scholar
• Pritham UA, Paul JA, Hayes MJ. Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome. J Obstet Gynecol Neonatal Nurs. 2012;41:180–190.
   PubMed Web of Science ®Google Scholar
• Kaltenbach K, Holbrook AM, Coyle MG, et al. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication. Addiction. 2012;107(Suppl 1):45–52.
   PubMed Web of Science ®Google Scholar
• Bakstad B, Sarfi M, Welle-Strand GK, Ravndal E. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study. Eur Addict Res. 2009;15:128–134.
   PubMed Web of Science ®Google Scholar
• Kacinko SL, Jones HE, Johnson RE, Choo RE, Huestis MA. Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes. Clin Pharmacol Ther. 2008;84:604–612.
   PubMed Web of Science ®Google Scholar
• Jones HE, Dengler E, Garrison A, et al. Neonatal outcomes and their relationship to maternal buprenorphine dose during pregnancy. Drug Alcohol Depend. 2014;134:414–417.
   PubMed Web of Science ®Google Scholar
• Fischer G, Etzersdorfer P, Eder H, Jagsch R, Langer M, Weninger M. Buprenorphine maintenance in pregnant opiate addicts. Eur Addict Res. 1998;4(Suppl 1):32–36.
   PubMed Web of Science ®Google Scholar
• Schindler SD, Eder H, Ortner R, Rohrmeister K, Langer M, Fischer G. Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction. 2003;98:103–110.
   PubMed Web of Science ®Google Scholar
• Ebner N, Rohrmeister K, Winklbaur B, et al. Management of neonatal abstinence syndrome in neonates born to opioid maintained women. Drug Alcohol Depend. 2007;87:131–138.
   PubMed Web of Science ®Google Scholar
• Unger A, Jagsch R, Jones H, et al. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison. Addiction. 2011;106:1355–1362.
   PubMed Web of Science ®Google Scholar
• Floch-Tudal C, Simonpoli AM, Montamat S, Couettoux MP, Crenn-Hebert C, Lejeune C. [Neonatal withdrawal syndrome in twins born to a mother on methadone substitution]. Ann Med Interne. 2000;151:30–33.
   PubMedGoogle Scholar
• Dahan S, Elefant E, Girard I, Azcona B, Champion V, Mitanchez D. [Neonatal seizures, buprenorphine abstinence syndrome, and substitutive treatment with morphine]. Arch Pediatrie. 2011;18:287–290.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Guidelines for the identification and management of substance use and substance use disorders in pregnancy. http://apps.who.int/iris/bitstream/10665/107130/1/9789241548731_eng.pdf. Published 2014. Accessed February 2016.
   Google Scholar
• Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures, United States, 2000–2009. JAMA. 2012;307:1934–1940.
   PubMed Web of Science ®Google Scholar
• United Nations. Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health. http://www.refworld.org/pdfid/4aa762e30.pdf. Published April 2010. Accessed March 2016.
   Google Scholar
• Stringer KL, Baker EH. Stigma as a barrier to substance abuse treatment among those with unmet need: an analysis of parenthood and marital status. J Fam Issues. 2015; doi: 10.1177/0192513X15581659.
   Google Scholar
• Heil SH, Jones HE, Arria A, et al. Unintended pregnancy in opioid abusing women. J Subst Abuse Treat. 2011;40:199–202.
   PubMed Web of Science ®Google Scholar
• Fowler C, Reid S, Minnis J, Day C. Experiences of mothers with substance dependence: informing the development of parenting support. J Clin Nurs. 2014;23:2835–2843.
   PubMed Web of Science ®Google Scholar